Dr. van den Brink joins City of Hope after 24 years at Memorial Sloan Kettering Cancer Center in New York City, where he most recently led its division of hematologic malignancies, according to an Aug. 29 news release.
He has also served as vice chair of the board of the Deutsche Knochenmark Stiftung, a global blood stem cell donor registration organization.
In addition to his role as president, Dr. van den Brink will also serve as chief physician executive and the Deana and Steve Campbell Chief Physician Executive Distinguished Chair.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
